Skip to Main Content
Table 1.

Tissue pharmacokinetics of CPT-11 formulations given by CED

Brain
t1/2 (d)AUC∞ (μg d/g)Clearance (g/d)Mean residence time (d)
60 μg free CPT-11 0.3 16.4 3.6 0.4 
60 μg nanoliposomal CPT-11 6.7 417 0.14 9.6 
0.8 mg nanoliposomal CPT-11 10.7 13,723 0.058 15.4 
1.6 mg nanoliposomal CPT-11 19.7 26,823 0.06 28.5 
     
U87 Tumor
 		    
 t1/2 (d) AUC∞ (μg d/g) Clearance (g/d) Mean residence time (d) 
0.8 mg nanoliposomal CPT-11 43.0 40,315 0.02 62.0 
Brain
t1/2 (d)AUC∞ (μg d/g)Clearance (g/d)Mean residence time (d)
60 μg free CPT-11 0.3 16.4 3.6 0.4 
60 μg nanoliposomal CPT-11 6.7 417 0.14 9.6 
0.8 mg nanoliposomal CPT-11 10.7 13,723 0.058 15.4 
1.6 mg nanoliposomal CPT-11 19.7 26,823 0.06 28.5 
     
U87 Tumor
 		    
 t1/2 (d) AUC∞ (μg d/g) Clearance (g/d) Mean residence time (d) 
0.8 mg nanoliposomal CPT-11 43.0 40,315 0.02 62.0 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept